Skip to content

Harpoon Therapeutics, Inc.

CIK 0001708493

← back to feed
Revenue (TTM)
$46.87M
+34.9% YoY Q3 Oct 2023
Net Income (TTM)
−$23.72M
+42.0% YoY Q3 Oct 2023
EPS Diluted (TTM)
−$4.26
+43.6% YoY Q3 Oct 2023
Gross Margin
—
Q3 Oct 2023
Operating Margin
-68.9%
Q3 Oct 2023
Net Margin
-50.6%
Q3 Oct 2023
Free Cash Flow (TTM)
−$80.67M
Q3 Oct 2023
Cash
$17.74M
Q3 Oct 2023
Total Debt
—
Q3 Oct 2023
Shares Outstanding
16.93M sh
Q3 Oct 2023

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings